These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 4679217)

  • 1. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
    Uchida K; Morimoto S; Takeda R; Murakami M
    Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathogenesis of essential hypertension with suppressed plasma renin activity].
    Uchida K
    Nihon Naibunpi Gakkai Zasshi; 1972 Dec; 48(9):674-84. PubMed ID: 4675750
    [No Abstract]   [Full Text] [Related]  

  • 3. Spironolactone as a nonspecific treatment for primary aldosteronism.
    Bravo EL; Dustan HP; Tarazi RC
    Circulation; 1973 Sep; 48(3):491-8. PubMed ID: 4726231
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension.
    Abe K; Yasujima M; Sakurai Y; Chiba S; Itoh T; Imai Y; Sato M; Haruyama T; Omata K; Goto T; Sato K; Hiwatari M; Otsuka Y; Yoshinaga K
    Jpn Circ J; 1979 Dec; 43(12):1105-16. PubMed ID: 396385
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism.
    Ichikawa S; Tajima Y; Sakamaki T; Matsuo H; Kogure M; Hirano Y; Yagi S; Murata K
    Jpn Circ J; 1984 Nov; 48(11):1184-96. PubMed ID: 6502914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressed plasma renin activity in essential hypertension. Roles of plasma volume, blood pressure, and sympathetic nervous system.
    Jose A; Crout JR; Kaplan NM
    Ann Intern Med; 1970 Jan; 72(1):9-16. PubMed ID: 4312105
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)].
    Helber A; Meurer KA; Rosskamp E; Wambach G; Dickmans HA; Kaufmann W
    Klin Wochenschr; 1974 Oct; 52(20):966-73. PubMed ID: 4444216
    [No Abstract]   [Full Text] [Related]  

  • 9. [The value of studying essential arterial hypertension with isotopic methods. Their application in arterial hypertension with low renin level].
    Olmer M; Salvadori JM; Paulin R; Sommer A; Marion J
    Nouv Presse Med; 1974 Feb; 3(5):233-6. PubMed ID: 4819942
    [No Abstract]   [Full Text] [Related]  

  • 10. Renin-angiotensin-aldosterone system of a woman with Bartter's syndrome: Juxtaglomerular cell hyperplasia without hypertension.
    Nakada T; Momose G; Yoshida T; Tateno Y; Shigematsu H
    J Urol; 1974 Sep; 112(3):293-8. PubMed ID: 4369140
    [No Abstract]   [Full Text] [Related]  

  • 11. Sodium and the renin-angiotensin system in essential hypertension and mineralocorticoid excess.
    Lebel M; Schalekamp MA; Beevers DG; Brown JJ; Davies DL; Fraser R; Kremer D; Lever AF; Morton JJ; Robertson JI; Tree M; Wilson A
    Lancet; 1974 Aug; 2(7876):308-9. PubMed ID: 4136047
    [No Abstract]   [Full Text] [Related]  

  • 12. [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].
    Klump F; Braun B; Klaus D; Lemke R; Zehner J; Zöfel P
    Dtsch Med Wochenschr; 1975 Mar; 100(12):577-84. PubMed ID: 1168122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.
    Vaughan ED; Laragh JH; Gavras I; Bühler FR; Gavras H; Brunner HR; Baer L
    Am J Cardiol; 1973 Sep; 32(4):523-32. PubMed ID: 4729722
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG; Hollifield JW; Liddle GW
    JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
    [No Abstract]   [Full Text] [Related]  

  • 15. Spironolactone and amiloride in hypertensive patients with and without aldosterone excess.
    Hoefnagels WH; Drayer JI; Smals AG; Kloppenborg PW
    Clin Pharmacol Ther; 1980 Mar; 27(3):317-23. PubMed ID: 6987022
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study on renin-angiotensin-aldosterone system. II. Changes of plasma renin activity, plasma aldosterone concentration and urinary sodium excretion in the hypertensives].
    Kawamata A
    Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):233-42. PubMed ID: 6379238
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma renin activity in panhypopituitarism. Responses to sodium restriction, furosemide and corticotrophin administration.
    Murakami M; Takeda R; Morimoto S; Hirasawa K; Uchida K
    Acta Endocrinol (Copenh); 1972 Mar; 69(3):531-41. PubMed ID: 4111287
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
    Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Imai Y; Saito K; Sakurai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in plasma renin activity after administration of spironolactone.
    Maebashi M; Yoshinaga K
    Jpn Circ J; 1967 Mar; 31(3):435-9. PubMed ID: 6072372
    [No Abstract]   [Full Text] [Related]  

  • 20. Similar effects of hydrochlorothiazide and spironolactone on plasma renin activity in essential hypertension.
    Acchiardo S; Dustan HP; Tarazi RC
    Cleve Clin Q; 1972; 39(4):153-62. PubMed ID: 4660197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.